Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,104,184 | 2,104,184 | 0 | $86.71M | $176.58M | 35.76% | +$89.87M |
| CG Oncology, Inc.(CGON) | 1,472,699 | 1,288,948 | -183,751 | $61.15M | $87.24M | 17.67% | +$26.09M |
| Oruka Therapeutics, Inc.(ORKA) | 660,424 | 760,424 | +100,000 | $20.02M | $37.30M | 7.55% | +$17.28M |
| Perspective Therapeutics, Inc.(CATX) | 3,210,733 | 6,049,999 | +2,839,266 | $8.83M | $25.23M | 5.11% | +$16.40M |
| Jade Biosciences Inc | 1,400,708 | 1,400,708 | 0 | $21.61M | $19.68M | 3.99% | -$1.93M |
| Enliven Therapeutics Inc | 140,300 | 400,000 | +259,700 | $2.16M | $15.68M | 3.18% | +$13.52M |
| Teva Pharmaceutical Industries Limited(TEVA) | 417,300 | 450,100 | +32,800 | $13.02M | $13.56M | 2.75% | +$533.1K |
| Context Therapeutics Inc.(CNTX) | 5,504,855 | 4,998,267 | -506,588 | $8.09M | $13.10M | 2.65% | +$5.00M |
| Repligen Corporation(RGEN) | 50,300 | 77,800 | +27,500 | $8.24M | $9.17M | 1.86% | +$924.2K |
| Palvella Therapeutics, Inc.(PVLA) | 19,300 | 70,000 | +50,700 | $2.02M | $8.73M | 1.77% | +$6.71M |
| Medtronic plcSHS(MDT) | 107,600 | 100,000 | -7,600 | $10.34M | $8.66M | 1.75% | -$1.67M |
| Vir Biotechnology, Inc.(VIR) | 0 | 950,000 | +950,000 | $0 | $8.51M | 1.72% | +$8.51M |
| Aktis Oncology, Inc.(AKTS) | 0 | 468,566 | +468,566 | $0 | $8.38M | 1.70% | +$8.38M |
| Immunic, Inc.(IMUX) | 4,699,411 | 6,699,411 | +2,000,000 | $2.51M | $7.44M | 1.51% | +$4.93M |
| DexCom, Inc.(DXCM) | 0 | 90,000 | +90,000 | $0 | $5.65M | 1.14% | +$5.65M |
| Encompass Health Corporation(EHC) | 31,600 | 42,000 | +10,400 | $3.35M | $4.06M | 0.82% | +$708.6K |
| Boston Scientific Corporation(BSX) | 114,500 | 60,000 | -54,500 | $10.92M | $3.77M | 0.76% | -$7.15M |
| Tenax Therapeutics, Inc.(TENX) | 0 | 215,934 | +215,934 | $0 | $3.45M | 0.70% | +$3.45M |
| Gilead Sciences, Inc.(GILD) | 0 | 20,000 | +20,000 | $0 | $2.79M | 0.56% | +$2.79M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 206,076 | 249,390 | +43,314 | $3.42M | $2.77M | 0.56% | -$648.1K |
| Karyopharm Therapeutics Inc.(KPTI) | 134,566 | 463,741 | +329,175 | $990.4K | $2.58M | 0.52% | +$1.59M |
| Centene Corporation(CNC) | 119,400 | 70,000 | -49,400 | $4.91M | $2.29M | 0.46% | -$2.62M |
| Satellos Bioscience Inc.(MSLE) | 0 | 387,769 | +387,769 | $0 | $2.18M | 0.44% | +$2.18M |
| SCYNEXIS, Inc.(SCYX) | 2,081,660 | 2,081,660 | 0 | $1.32M | $1.91M | 0.39% | +$592.2K |
| Natera, Inc.(NTRA) | 11,800 | 9,000 | -2,800 | $2.70M | $1.80M | 0.36% | -$903.4K |
| ICON Public Limited CompanySHS(ICLR) | 33,100 | 16,000 | -17,100 | $6.03M | $1.77M | 0.36% | -$4.26M |
| Kenvue Inc.(KVUE) | 232,800 | 100,000 | -132,800 | $4.02M | $1.72M | 0.35% | -$2.29M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 115,000 | +115,000 | $0 | $1.68M | 0.34% | +$1.68M |
| Hims & Hers Health, Inc.CL A(HIMS) | 0 | 75,000 | +75,000 | $0 | $1.56M | 0.32% | +$1.56M |
| Revolution Medicines, Inc.(RVMD) | 0 | 15,000 | +15,000 | $0 | $1.46M | 0.30% | +$1.46M |
| Structure Therapeutics IncADS | 0 | 30,000 | +30,000 | $0 | $1.45M | 0.29% | +$1.45M |
| Genmab A/SADS(GMAB) | 92,000 | 50,000 | -42,000 | $2.83M | $1.34M | 0.27% | -$1.49M |
| Corcept Therapeutics Incorporated(CORT) | 22,000 | 30,000 | +8,000 | $765.6K | $1.21M | 0.24% | +$443.7K |
| Tempus AI, Inc.CL A(TEM) | 0 | 25,000 | +25,000 | $0 | $1.13M | 0.23% | +$1.13M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 10,000 | +10,000 | $0 | $1.11M | 0.23% | +$1.11M |
| UnitedHealth Group Incorporated(UNH) | 0 | 3,800 | +3,800 | $0 | $1.03M | 0.21% | +$1.03M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 75,000 | +75,000 | $0 | $961.5K | 0.19% | +$961.5K |
| Oddity Tech Ltd-Cl ACL A SHS CL A | 0 | 70,000 | +70,000 | $0 | $936.6K | 0.19% | +$936.6K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 50,000 | +50,000 | $0 | $932.0K | 0.19% | +$932.0K |
| Peloton Interactive, Inc.CL A(PTON) | 0 | 200,000 | +200,000 | $0 | $858.0K | 0.17% | +$858.0K |
| Anteris Technologies Global Corp.(AVR) | 0 | 150,000 | +150,000 | $0 | $832.5K | 0.17% | +$832.5K |
| Arbutus Biopharma Corporation(ABUS) | 0 | 125,000 | +125,000 | $0 | $562.5K | 0.11% | +$562.5K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 43,853 | +43,853 | $0 | $392.5K | 0.08% | +$392.5K |
| Acadia Pharm | 106,900 | 12,967 | -93,933 | $2.86M | $288.6K | 0.06% | -$2.57M |
| Trevi Therapeutics, Inc.CL A(TRVI) | 0 | 6,660 | +6,660 | $0 | $79.5K | 0.02% | +$79.5K |
| Acadia Healthcare Company, Inc.(ACHC) | 169,000 | 0 | -169,000 | $2.40M | $0 | — | -$2.40M |
| Agilent Technologies, Inc.(A) | 41,500 | 0 | -41,500 | $5.65M | $0 | — | -$5.65M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 21,000 | 0 | -21,000 | $8.35M | $0 | — | -$8.35M |
| Cencora Inc | 9,400 | 0 | -9,400 | $3.17M | $0 | — | -$3.17M |
| Danaher Corporation(DHR) | 17,000 | 0 | -17,000 | $3.89M | $0 | — | -$3.89M |
| HealthEquity, Inc.(HQY) | 16,900 | 0 | -16,900 | $1.55M | $0 | — | -$1.55M |
| Insmed Incorporated(INSM) | 17,700 | 0 | -17,700 | $3.08M | $0 | — | -$3.08M |
| Integer Holdings Corporation(ITGR) | 29,800 | 0 | -29,800 | $2.34M | $0 | — | -$2.34M |
| IQVIA Holdings Inc.(IQV) | 4,400 | 0 | -4,400 | $991.8K | $0 | — | -$991.8K |
| McKesson Corporation(MCK) | 9,520 | 0 | -9,520 | $7.81M | $0 | — | -$7.81M |
| Novo Nordisk A/SADR(NVO) | 67,300 | 0 | -67,300 | $3.42M | $0 | — | -$3.42M |
| Pfizer Inc.(PFE) | 203,600 | 0 | -203,600 | $5.07M | $0 | — | -$5.07M |
| The Cigna Group(CI) | 11,600 | 0 | -11,600 | $3.19M | $0 | — | -$3.19M |
| Thermo Fisher Scientific Inc.(TMO) | 6,700 | 0 | -6,700 | $3.88M | $0 | — | -$3.88M |
| Waters Corporation(WAT) | 8,100 | 0 | -8,100 | $3.08M | $0 | — | -$3.08M |